Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: A Cross-Sectional Survey

Abstract

The health of people with chronic diabetes mellitus (DM) complications will worsen following coronavirus disease 2019 (COVID-19) infection. This cross-sectional study compared perceptions and factors related to COVID-19 vaccination uptake between subgroups of DM inpatients with and without chronic complications in China. A multivariate logistic regression model was used for data analysis. Of the 645 participants, those without any complications reported significantly higher uptake of at least one dose of COVID-19 vaccination (43.2% versus 11.2%, p < 0.001). For people with chronic DM complications, a perception of higher risk and severer consequences of COVID-19 infection, a belief that doctors would suggest they receive COVID-19 vaccination, and a belief that relatives’ vaccination uptake would influence their own decision to receive a COVID-19 vaccination were all associated with higher COVID-19 vaccination uptake. For their counterparts without chronic complications, a perception of severer consequences of COVID-19 infection, a belief that receiving COVID-19 vaccination could reduce the risk of infection, and a belief that relatives’ vaccination uptake would influence their own decision to receive a COVID-19 vaccination were all associated with higher COVID-19 vaccination uptake. Concerns about the safety and the side effects of vaccination were negatively associated with COVID-19 vaccination uptake in both groups of DM patients. Different strategies might be applied to promote COVID-19 vaccination uptake in DM patients with and without chronic complications.

Factors associated with full COVID-19 vaccination among persons living with diabetes mellitus in Uganda – A Cross-sectional Study

“…One interesting nding of this study was the nonsigni cant in uence of the perceived severity of COVID-19 infection on the likelihood of receiving full vaccination among persons with DM. This nding contradicts ndings from other studies conducted among persons with DM in China (19,36). This contradiction is potentially explained by the different patterns of the pandemic with fewer reported COVID-19 cases and deaths in Uganda than in Eastern Asia (1).…”

“…Having a comorbidity potentially increases the perceived risk of severe COVID-19 outcomes among people with DM making them less hesitant to accept COVID-19 vaccination (19,33). However, interestingly, this study revealed that more participants with a strongly perceived severity of COVID-19 were not fully vaccinated than were those with a weakly perceived severity of COVID-19 infection, a nding that supports the notion that perceived severity is less likely to predict health behavior (23).…”

Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among Chinese cancer patients: A multicentre cross-sectional survey

“…The same checklist was used to measure self-reported adverse events of COVID-19 vaccination among general population 39 and diabetic patients in China. 40 …”

Is knowledge about COVID-19 associated with willingness to receive vaccine, vaccine uptake, and vaccine booster uptake in rural Malang, Indonesia?

“…Higher COVID-19 vaccine coverage among people with comorbidities in the UK might be explained by the fact that the UK used risk-based scheduling that prioritized people with comorbidities, e.g., hypertension and type 2 diabetes, for early vaccination ( 49 ). A study in China found that only 25.1% of people with diabetes mellitus received COVID-19 vaccination and this proportion was far below the rate in the general population (88%) ( 50 ). Furthermore, hospitalized patients with diabetes mellitus and chronic complications had a lower COVID-19 vaccine coverage (11.2%) than those without chronic complications (43.2%).…”